Literature DB >> 10609819

Serum concentrations of organochlorine compounds and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group.

M Porta1, N Malats, M Jariod, J O Grimalt, J Rifà, A Carrato, L Guarner, A Salas, M Santiago-Silva, J M Corominas, M Andreu, F X Real.   

Abstract

BACKGROUND: Organochlorine compounds such as 1,1,1-trichloro-2,2-bis(p-chlorophenyl)-ethane (p,p'-DDT), 1,1-dichloro-2,2-bis(p-chlorophenyl) ethylene (p,p'-DDE), and some polychlorinated biphenyls (PCBs) are carcinogenic to animals and possibly also to human beings. Occupational exposure to DDT may increase the risk of pancreas cancer. The high frequency of K-ras mutations in pancreatic cancer remains unexplained. We analysed the relation between serum concentrations of selected organochlorine compounds and mutations in codon 12 of the K-ras gene in patients with exocrine pancreatic cancer.
METHODS: Cases were prospectively identified in five hospitals. Mutations in K-ras were analysed by PCR and artificial restriction fragment length polymorphism. Cases of pancreatic cancer with wild-type K-ras (n=17) were frequency matched for age and sex to cases of pancreatic cancer with a K-ras mutation (n=34, case-case study). These 51 cases were further compared with 26 hospital controls (case-control comparison). Serum organochlorine concentrations were measured by high-resolution gas chromatography with electron-capture detection and negative ion chemical ionisation mass spectrometry.
FINDINGS: Serum concentrations of p,p'-DDT were significantly higher in pancreatic cancer cases with a K-ras mutation than in cases without a mutation (odds ratio for upper tertile 8.7 [95% CI 1.6-48.5], p for trend=0.005). For p,p'-DDE the corresponding figures were 5.3 (1.1-25.2, p for trend=0.031). These estimates held after adjusting for total lipids, other covariates, and total PCBs. A specific association was observed between a glycine to valine substitution at codon 12 and both p,p'-DDT and p,p'-DDE concentrations (odds ratio 15.9, p=0.044 and odds ratio 24.1, p=0.028; respectively). A similar pattern was shown for the major di-ortho-chlorinated PCBs (congeners 138, 153, and 180), even after adjustment for p,p'-DDE, but without a specific association with spectrum. Concentrations of p,p'-DDT and p,p'-DDE were similar among wild-type cases and controls, but significantly higher for K-ras mutated cases than for controls (p<0.01).
INTERPRETATION: Organochlorine compounds such as p,p'-DDT, p,p'-DDE, and some PCBs could play a part in the pathogenesis of exocrine pancreatic cancer through modulation of K-ras activation. The results require replication, but they suggest new roles for organochlorines in the development of several cancers in human beings.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10609819     DOI: 10.1016/s0140-6736(99)04232-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  31 in total

Review 1.  Occupational risk factors and pancreatic cancer: a review of recent findings.

Authors:  Gabriella Andreotti; Debra T Silverman
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

2.  Occupational exposures and risk of pancreatic cancer.

Authors:  Miguel Santibañez; Jesús Vioque; Juan Alguacil; Manuela García de la Hera; Eduardo Moreno-Osset; Alfredo Carrato; Miquel Porta; Timo Kauppinen
Journal:  Eur J Epidemiol       Date:  2010-07-17       Impact factor: 8.082

3.  Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage.

Authors:  Miquel Porta; Xavier Fabregat; Núria Malats; Luisa Guarner; Alfredo Carrato; Ana de Miguel; Laura Ruiz; Manuel Jariod; Sergi Costafreda; Susana Coll; Juan Alguacil; Josep M Corominas; Ricard Solà; Antonio Salas; Francisco X Real
Journal:  Clin Transl Oncol       Date:  2005-06       Impact factor: 3.405

4.  Timing of blood extraction in epidemiologic and proteomic studies: results and proposals from the PANKRAS II Study.

Authors:  Miquel Porta; José Pumarega; Olga Ferrer-Armengou; Tomàs López; Joan Alguacil; Núria Malats; Esteve Fernàndez
Journal:  Eur J Epidemiol       Date:  2007-07-18       Impact factor: 8.082

5.  K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients: in relation to cigarette smoking.

Authors:  Li Jiao; Jijiang Zhu; Manal M Hassan; Douglas B Evans; James L Abbruzzese; Donghui Li
Journal:  Pancreas       Date:  2007-01       Impact factor: 3.327

6.  Estimating dietary intakes from a brief questionnaire: A simulation study of reliability in a molecular epidemiologic study of pancreatic and biliary diseases.

Authors:  Michelle A Mendez; Jesús Vioque; Miquel Porta; Eva Morales; Tomàs López; Núria Malats; Marta Crous; Luis I Gómez
Journal:  Eur J Epidemiol       Date:  2006-07-08       Impact factor: 8.082

7.  Validity of the hospital discharge diagnosis in epidemiologic studies of biliopancreatic pathology. PANKRAS II Study Group.

Authors:  M Porta; S Costafreda; N Malats; L Guarner; M Soler; J M Gubern; E García-Olivares; M Andreu; A Salas; J M Corominas; J Alguacil; A Carrato; J Rifà; F X Real
Journal:  Eur J Epidemiol       Date:  2000-06       Impact factor: 8.082

8.  Simultaneous analysis of organochlorine pesticides and polychlorinated biphenyls in air samples by using accelerated solvent extraction (ASE) and solid-phase micro-extraction (SPME) coupled to gas chromatography dual electron capture detection.

Authors:  Haifaa Mokbel; Enaam Jamal Al Dine; Ahmad Elmoll; Céline Liaud; Maurice Millet
Journal:  Environ Sci Pollut Res Int       Date:  2016-01-16       Impact factor: 4.223

9.  Agricultural pesticide use and pancreatic cancer risk in the Agricultural Health Study Cohort.

Authors:  Gabriella Andreotti; Laura E Beane Freeman; Lifang Hou; Joseph Coble; Jennifer Rusiecki; Jane A Hoppin; Debra T Silverman; Michael C R Alavanja
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

10.  CYP1B1 polymorphisms and k-ras mutations in patients with pancreatic ductal adenocarcinoma.

Authors:  Marta Crous-Bou; Immaculata De Vivo; Miquel Porta; José A Pumarega; Tomàs López; Joan Alguacil; Eva Morales; Núria Malats; Juli Rifà; David J Hunter; Francisco X Real
Journal:  Dig Dis Sci       Date:  2008-03-18       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.